Drug Interactions and Side Effects Analysis of Sulfasalazine and Metformin Hcl and Nexium and Purinethol and Konakion and Noroxin and Bactrim and Metoprolol Tartrate and Zyrtec and Spiriva
>>> Check drugs in a new way
| Report ID | Date of report | Patient age | Patient gender |
| 54013 | Feb, 17, 2006 | 56 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Sulfasalazine | sulfasalazine |
Metformin Hcl | metformin hydrochloride |
Nexium | esomeprazole magnesium |
Purinethol | mercaptopurine |
Konakion | phytonadione |
Noroxin | norfloxacin |
Bactrim | sulfamethoxazole; trimethoprim |
Metoprolol Tartrate | metoprolol tartrate |
Zyrtec | cetirizine hydrochloride |
Spiriva | tiotropium bromide monohydrate |
| Name |
Acute Abdomen |
Anaemia Macrocytic |
Asthenia |
Dialysis |
Faecal Vomiting |
Haemodynamic Instability |
Hepatic Trauma |
Hepatitis |
Lactic Acidosis |
Malabsorption |
Metabolic Acidosis |
Multi-organ Failure |
Pancreatitis Acute |
Renal Failure Acute |
Respiratory Failure |
Vitamin B12 Deficiency |
Results from eHealthMe : 1 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Acute Abdomen | 1 (100.00%) |
Anaemia Macrocytic | 1 (100.00%) |
Asthenia | 1 (100.00%) |
Dialysis | 1 (100.00%) |
Faecal Vomiting | 1 (100.00%) |
Haemodynamic Instability | 1 (100.00%) |
Hepatic Trauma | 1 (100.00%) |
Hepatitis | 1 (100.00%) |
Lactic Acidosis | 1 (100.00%) |
Malabsorption | 1 (100.00%) |
Metabolic Acidosis | 1 (100.00%) |
Multi-organ Failure | 1 (100.00%) |
Pancreatitis Acute | 1 (100.00%) |
Renal Failure Acute | 1 (100.00%) |
Respiratory Failure | 1 (100.00%) |
Vitamin B12 Deficiency | 1 (100.00%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 0
| Name | Count (% of total reports) |
Multi-organ Failure | 1 (100.00%) |
Metabolic Acidosis | 1 (100.00%) |
Malabsorption | 1 (100.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
